Marika Ruponen
- Molecular Biology top 5%
- Genetics top 5%
- Pharmaceutical Science top 0.5%
- Public Health, Environmental and Occupational Health top 5%
- Ophthalmology top 1%
- Co-authors
- Arto UrttiSeppo Ylä‐HerttualaEva M. del AmoPaavo HonkakoskiMarkku TammiElisa ToropainenSeppo RönkköKati‐Sisko Vellonen
- Topics
- RNA Interference and Gene Delivery (27 papers)Virus-based gene therapy research (17 papers)Advanced Drug Delivery Systems (17 papers)
In The Last Decade
Marika Ruponen
90 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 108
- Molecular Biology 2.0k
- Genetics 598
- Pharmaceutical Science 586
- Public Health, Environmental and Occupational Health 440
- Ophthalmology 411
Countries citing papers authored by Marika Ruponen
This map shows the geographic impact of Marika Ruponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marika Ruponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marika Ruponen more than expected).
Fields of papers citing papers by Marika Ruponen
This network shows the impact of papers produced by Marika Ruponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marika Ruponen. The network helps show where Marika Ruponen may publish in the future.
Co-authorship network of co-authors of Marika Ruponen
This figure shows the co-authorship network connecting the top 25 collaborators of Marika Ruponen. A scholar is included among the top collaborators of Marika Ruponen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marika Ruponen. Marika Ruponen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 9 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 8 | |
| 11 | 25 | |
| 12 | 18 | |
| 13 | 11 | |
| 14 | 13 | |
| 15 | 177 | |
| 16 | 46 | |
| 17 | 4 | |
| 18 | 17 | |
| 19 | 59 | |
| 20 | 93 |
About Marika Ruponen
Marika Ruponen is a scholar working on Pharmaceutical Science, Ophthalmology and Molecular Biology, having authored 93 papers that have together received 3.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (27 papers), Virus-based gene therapy research (17 papers) and Advanced Drug Delivery Systems (17 papers). The work is most often cited by research in Pharmaceutical Science (586 citations), Ophthalmology (411 citations) and Molecular Biology (2.0k citations). Marika Ruponen has collaborated with scholars based in Finland, Russia and Italy. Frequent co-authors include Arto Urtti, Seppo Ylä‐Herttuala, Eva M. del Amo, Paavo Honkakoski, Markku Tammi, Elisa Toropainen, Seppo Rönkkö, Kati‐Sisko Vellonen, Veli‐Pekka Ranta and Jukka Pelkonen. Their work appears in journals such as Journal of Biological Chemistry, Advanced Drug Delivery Reviews and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.